The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Eltrombopag (Brand name: Promacta®)
- Manufactured by
FDA-approved indication: Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
National Library of Medicine Drug Information PortalMedline Plus Health Information